TSH Biopharm Corporation Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	464.54	588.34	576.59	488.9	381.89
Short-Term Investments	467.74	309.02	195.54	326.86	351.52
Cash & Short-Term Investments	932.28	897.36	772.12	815.77	733.41
Cash Growth	3.89%	16.22%	-5.35%	11.23%	1.07%
Accounts Receivable	312.34	211.68	208.33	202.55	99.07
Other Receivables	2.35	2.39	2.18	1.83	1.06
Receivables	314.69	214.07	210.51	204.38	100.13
Inventory	155.74	176.08	118.4	107.39	73.22
Prepaid Expenses	18.54	16.79	9.29	-	-
Other Current Assets	1.77	0.41	3.44	15.37	13.22
Total Current Assets	1,423	1,305	1,114	1,143	919.97
Property, Plant & Equipment	35.64	40.41	32.68	41.64	27.36
Long-Term Investments	183.84	192.63	188.89	179.08	212.06
Goodwill	247.9	247.9	-	-	-
Other Intangible Assets	41.58	39.75	53.64	64.07	3.63
Long-Term Deferred Tax Assets	2.67	4.01	1.51	1.8	2.01
Other Long-Term Assets	16.8	12.78	9.39	5.62	4.39
Total Assets	1,951	1,842	1,400	1,435	1,169
Accounts Payable	48.63	71.36	51.42	57.64	12.72
Accrued Expenses	67.87	56.69	35.21	37.4	44.77
Short-Term Debt	-	-	-	20	-
Current Portion of Long-Term Debt	-	-	-	18.85	-
Current Portion of Leases	11.95	10.1	7.4	7.32	4.57
Current Income Taxes Payable	26.68	32.23	2.97	8.02	7.1
Current Unearned Revenue	3.24	1.04	1.84	5.43	-
Other Current Liabilities	68.73	37.48	34.79	50.85	16.64
Total Current Liabilities	227.09	208.9	133.63	205.5	85.8
Long-Term Debt	-	-	-	9.6	-
Long-Term Leases	6.7	10.33	-	7.36	-
Total Liabilities	233.79	219.23	133.63	222.46	85.8
Common Stock	383.98	383.98	383.98	383.98	383.98
Additional Paid-In Capital	459.61	459.55	459.5	459.44	459.36
Retained Earnings	581.2	480.68	204.14	228.37	224.08
Comprehensive Income & Other	17.82	67.58	59.98	22.58	16.21
Total Common Equity	1,443	1,392	1,108	1,094	1,084
Minority Interest	275.06	231.18	158.63	118.31	-
Shareholders' Equity	1,718	1,623	1,266	1,213	1,084
Total Liabilities & Equity	1,951	1,842	1,400	1,435	1,169
Total Debt	18.64	20.43	7.4	63.13	4.57
Net Cash (Debt)	913.64	876.93	764.73	752.64	728.84
Net Cash Growth	4.19%	14.67%	1.60%	3.27%	1.67%
Net Cash Per Share	23.75	22.81	19.90	19.57	18.96
Filing Date Shares Outstanding	38.4	38.4	38.4	38.4	38.4
Total Common Shares Outstanding	38.4	38.4	38.4	38.4	38.4
Working Capital	1,196	1,096	980.13	937.41	834.17
Book Value Per Share	37.57	36.25	28.85	28.50	28.22
Tangible Book Value	1,153	1,104	1,054	1,030	1,080
Tangible Book Value Per Share	30.03	28.76	27.45	26.83	28.13
Land	5.85	5.85	5.85	5.85	5.85
Buildings	14.2	14.2	14.2	13.94	13.94
Machinery	48.21	47.68	33.13	31.41	22.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.